Evaluation of neutrophil activation in autoimmune kidney diseases using blood heparin-binding protein: a pilot study

Key Points

• Neutrophil activation is widespread in autoimmune kidney diseases, indicating a potential role in pathogenesis.
• Blood heparin-binding protein (HBP) serves as an important marker, independent of eGFR levels.
• The study highlights the necessity of exploring neutrophil activation mechanisms for better understanding of these diseases.
• Findings may lead to new approaches in the assessment and treatment of autoimmune kidney disorders.

Abstract